Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYАктуальные проблемы теоретической и клинической медицины

CLINICAL CASE OF CO-INFECTION MYCOBACTERIOSIS AND DRUG-RESISTANT PULMONARY TUBERCULOSIS

  • M. B. Istelyuyeva1
  • F. A. Iskakova2
  • Kh. M. Dautova3
  1. 1National Scientific Center of Phthisiopulmonology
  2. 2Al-Farabi Kazakh National University
  3. 3S. D. Asfendiarov Kazakh National Medical University
Read full textDOICite

Abstract

Relevance. In recent years, there has been an increase in nontuberculous mycobacteriosis, including cases combined with pulmonary tuberculosis. Diagnosis of co-infection is challenging due to the similarity of clinical and radiological findings, while treatment presents a complex task because of the heterogeneous drug susceptibility of the pathogens.Case Description. We present a case of a 49-year-old female patient with recurrent drug-resistant pulmonary tuberculosis, chronic obstructive pulmonary disease, and severe underweight (Body Mass Index 15.0). Examination using the GenoType® Mycobacterium CM method confirmed co-infection with M. tuberculosis and M. avium complex. The patient was prescribed an individualized chemotherapy regimen including bedaquiline, linezolid, clofazimine, levofloxacin, cycloserine, and clarithromycin.Results. After 8 months of treatment, sputum conversion was achieved (negative sputum smear microscopy and culture), with favorable radiological changes and clinical improvement.Conclusion. This case demonstrates the fundamental possibility of successful treatment of drug-resistant pulmonary tuberculosis and nontuberculous mycobacteriosis co-infection using a combination of reserve anti-tuberculosis drugs and macrolides, despite diagnostic limitations, the complexity of selecting a chemotherapy regimen, and challenges in patient routing for those with co-infection.

Related

  1. Metagenomic insights into the pulmonary microbiome of drug-sensitive and multidrug-resistant tuberculosis patients
    Zhi-Ruo Lin, Ji-Chan Shi, Chao-Chao Qiu +9
    Annals of medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Prevalence of post-tuberculosis lung disease and its clinical, radiological and pulmonary function characteristics: a cross-sectional observational study
    Deependra Kumar Rai, Parul Sharma, Upasna Sinha
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  3. Differential diagnosis of pulmonary Talaromyces marneffei infection and pulmonary tuberculosis in HIV/AIDS patients using a CT-based multimodal 2.5D deep learning approach
    Chang Song, Chang Song, Chun-Yan Zhao +8
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJEurope PMCPMC
  4. Time to sputum culture conversion and associated factors among rifampicin-resistant pulmonary tuberculosis patients treated with Bedaquiline at Mulago hospital, Uganda.
    Martha Namusobya, Felix Bongomin, Lois Keren Kisakye +5
    BMC infectious diseasesPeer-reviewedCC BY-NC-NDFull textInfectious diseaseEurope PMCPMC
  5. Severe Evans Syndrome at the Infection-Inflammation-Autoimmunity Interface During Bacteriologically Confirmed Pulmonary Tuberculosis: A Case Report.
    Xueming Xie
    Journal of inflammation researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{istelyuyeva2026clinical,
  title = {{CLINICAL CASE OF CO-INFECTION MYCOBACTERIOSIS AND DRUG-RESISTANT PULMONARY TUBERCULOSIS}},
  author = {M. B. Istelyuyeva and F. A. Iskakova and Kh. M. Dautova},
  journal = {Актуальные проблемы теоретической и клинической медицины},
  year = {2026},
  month = jul,
  doi = {10.64854/2790-1289-2026-52-2-07},
  url = {https://doi.org/10.64854/2790-1289-2026-52-2-07},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - CLINICAL CASE OF CO-INFECTION MYCOBACTERIOSIS AND DRUG-RESISTANT PULMONARY TUBERCULOSIS
AU  - M. B. Istelyuyeva
AU  - F. A. Iskakova
AU  - Kh. M. Dautova
PY  - 2026
DA  - 2026/07/01
JO  - Актуальные проблемы теоретической и клинической медицины
DO  - 10.64854/2790-1289-2026-52-2-07
UR  - https://doi.org/10.64854/2790-1289-2026-52-2-07
AB  - Relevance. In recent years, there has been an increase in nontuberculous mycobacteriosis, including cases combined with pulmonary tuberculosis. Diagnosis of co-infection is challenging due to the similarity of clinical and radiological findings, while treatment presents a complex task because of the heterogeneous drug susceptibility of the pathogens.Case Description. We present a case of a 49-year-old female patient with recurrent drug-resistant pulmonary tuberculosis, chronic obstructive pulmonary disease, and severe underweight (Body Mass Index 15.0). Examination using the GenoType® Mycobacterium CM method confirmed co-infection with M. tuberculosis and M. avium complex. The patient was prescribed an individualized chemotherapy regimen including bedaquiline, linezolid, clofazimine, levofloxacin, cycloserine, and clarithromycin.Results. After 8 months of treatment, sputum conversion was achieved (negative sputum smear microscopy and culture), with favorable radiological changes and clinical improvement.Conclusion. This case demonstrates the fundamental possibility of successful treatment of drug-resistant pulmonary tuberculosis and nontuberculous mycobacteriosis co-infection using a combination of reserve anti-tuberculosis drugs and macrolides, despite diagnostic limitations, the complexity of selecting a chemotherapy regimen, and challenges in patient routing for those with co-infection.
SN  - 2790-1289
SN  - 2790-1297
ER  -